Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.
Visit
A session filmed at the 64th ASH Annual Meeting and Exposition, featuring leading experts Michael Dickinson and Tycel Phillips, who discuss clinical trial updates in MCL, the changing status of transplantation in NHL, and the growing role of bispecific antibodies in NHL.
Welcome to The Lymphoma Sessions brought to you by the Video Journal of Hematological Oncology (VJHemOnc). This exclusive session features leading experts Michael Dickinson, MBBS, DMedSc, FRACP, FRACPA, Peter MacCallum Cancer Centre, Melbourne, Australia, and Tycel Phillips, MD, City of Hope, Duarte, CA, who share key updates in non-Hodgkin lymphoma (NHL) at the 64th ASH Annual Meeting and Exposition congress. The experts draw focus on clinical trial updates in mantle cell lymphoma (MCL) and the space of BTK inhibitors in the frontline treatment of MCL. The experts further discuss the use of glofitamab in relapsed/refractory (R/R) MCL and aggressive large B-cell lymphoma (LBCL), and the evolving status of transplantation in NHL.
The Lymphoma Channel on VJHemOnc receives independent medical education support from:
